Tag Archive for: Pharma

Futura Medical – Jeff Needham to succeed John Clarke as Non-Executive Chairman of Futura Medical plc

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology focused on sexual health, announces that Non-Executive Chairman, John Clarke has stepped down and is succeeded by existing Non-Executive board member, Jeff Needham. Read more…

Futura Medical Announces Agreement With Haleon To Commercialise MED3000 In The USA

Futura Medical plc (AIM: FUM) (“Futura” or the “Company”), a pharmaceutical company developing a portfolio of innovative products based on its proprietary, transdermal DermaSys® drug delivery technology, focused on sexual health, today announces that it has entered into a ground breaking licensing agreement with Haleon plc (“Haleon”), a world leading consumer healthcare Company for the rights to […]

Neuraxpharm expands outside Europe into Brazil and Mexico

Recently acquired Sanofi portfolio products to be combined with acquired Libber Pharma infrastructure to build new affiliate in Brazil Products in Mexico to be distributed through newly established greenfield affiliate  Barcelona and Düsseldorf – July 11, 2023 – Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) […]

How is AI being used to improve healthcare?

LET’S play a word association game. AI. Healthcare. Are you thinking what I’m thinking?  If so, you‘re thinking about drug discovery.  It is a very hot topic in pharma right now. Billions are being poured into efforts to use artificial intelligence (AI) to spot new drugs.  And for good reason. ‘Traditional’ drug discovery methods are […]

Lonza to Acquire Synaffix and Strengthen Antibody-Drug Conjugates Offering

Lonza to acquire Synaffix B.V., an innovative biotech company focused on antibody-drug conjugates (ADCs) Acquisition will further strengthen Lonza’s bioconjugates offering through the integration of the industry-leading proprietary Synaffix technology platform and R&D capabilities, including payload and site-specific linker technology Lonza and Synaffix will continue to expand their Center of Excellence for bioconjugate technology development, […]